2014
DOI: 10.1016/j.jff.2014.08.025
|View full text |Cite
|
Sign up to set email alerts
|

Effect of ergosterol-enriched extracts obtained from Agaricus bisporus on cholesterol absorption using an in vitro digestion model

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
27
0

Year Published

2015
2015
2023
2023

Publication Types

Select...
6
2

Relationship

1
7

Authors

Journals

citations
Cited by 45 publications
(28 citation statements)
references
References 31 publications
0
27
0
Order By: Relevance
“…Cholesterol lowering in serum can be achieved via several mechanisms but mainly by impairing of exogenous cholesterol absorption or inhibiting endogenous cholesterol biosynthesis. The hypocholesterolemic activity of the obtained fractions was evaluated as their ability to inhibit the key enzyme of the cholesterol biosynthetic pathway (HMGCR) since the capacity to impair cholesterol absorption was already evaluated elsewhere for similar extracts containing high ergosterol levels (as ExB) and high β‐glucans and dietary fibers contents (as respectively, ExC and ReC) . The initial shiikate powder showed a remarkable HMGCR inhibitory activity acting as pravastatin used as control (Figure ).…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Cholesterol lowering in serum can be achieved via several mechanisms but mainly by impairing of exogenous cholesterol absorption or inhibiting endogenous cholesterol biosynthesis. The hypocholesterolemic activity of the obtained fractions was evaluated as their ability to inhibit the key enzyme of the cholesterol biosynthetic pathway (HMGCR) since the capacity to impair cholesterol absorption was already evaluated elsewhere for similar extracts containing high ergosterol levels (as ExB) and high β‐glucans and dietary fibers contents (as respectively, ExC and ReC) . The initial shiikate powder showed a remarkable HMGCR inhibitory activity acting as pravastatin used as control (Figure ).…”
Section: Resultsmentioning
confidence: 99%
“…Edible mushrooms are natural sources of hypocholesterolemic compounds, such as fungal sterols (ergosterol and derivatives) and polysaccharides (β‐glucans, chitins, etc.) that according to in vitro experiments might inhibit cholesterol absorption and biosynthesis . Eritadenine (2( R ),3( R )‐dihydroxy‐4‐(9‐adenyl) butanoic acid) from Lentinula edodes (shiitake mushrooms) was also able to lower cholesterol levels by acting as an inhibitor of the S‐adenosyl‐L‐homocysteine hydrolase involved in the hepatic phospholipid metabolism .…”
Section: Introductionmentioning
confidence: 99%
“…In recent years, mycosterols have gained attention from the scientific community as potential functional ingredients for the development of sterol-enriched food products and dietary supplements. 1 Numerous studies have indicated that ergosterol-rich fungi extracts are capable of reducing cholesterol absorption 2,3 and also of inhibiting its biosynthesis in the human body. 4,5 In addition, such extracts promote other health benefits such as anti-cancer, 6 antiproliferative, 7,8 antiinflammatory 9,10 and antimicrobial 11,12 effects.…”
Section: Introductionmentioning
confidence: 99%
“…It is the most abundant mycosterol, especially in Agaricus bisporus L. (90% of its sterols fraction) (Barreira et al, 2014;Gil-Ramírez et al, 2014), and has been related with different bioactive properties (Barreira and Ferreira, 2015;Villares et al, 2012). Moreover, ergosterol can be converted by irradiation, into vitamin D for sale as a dietary supplement and food additive (Asinghe and Perera, 2005;Teichmann et al, 2007).…”
Section: Introductionmentioning
confidence: 99%